$2.31T
Total marketcap
$106.39B
Total volume
BTC 49.83%     ETH 15.53%
Dominance

Sinopharm Group Co. Ltd. X2S.F Stock

2.29 EUR {{ price }} -1.292555% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
7.22B EUR
LOW - HIGH [24H]
2.29 - 2.29 EUR
VOLUME [24H]
4K EUR
{{ volume }}
P/E Ratio
6.19
Earnings per share
0.37 EUR

Sinopharm Group Co. Ltd. Price Chart

Sinopharm Group Co. Ltd. X2S.F Financial and Trading Overview

Sinopharm Group Co. Ltd. stock price 2.29 EUR
Previous Close 3.08 EUR
Open 2.99 EUR
Bid 2.96 EUR x 400000
Ask 3.01 EUR x 400000
Day's Range 2.99 - 2.99 EUR
52 Week Range 1.89 - 3.25 EUR
Volume 1K EUR
Avg. Volume 2.72K EUR
Market Cap 9.41B EUR
Beta (5Y Monthly) 0.819157
PE Ratio (TTM) 8.548572
EPS (TTM) 0.37 EUR
Forward Dividend & Yield 0.11 (3.57%)
Ex-Dividend Date June 19, 2023
1y Target Est N/A

X2S.F Valuation Measures

Enterprise Value 57.68B EUR
Trailing P/E 8.548572
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.016993737
Price/Book (mrq) 0.13786748
Enterprise Value/Revenue 0.104
Enterprise Value/EBITDA 2.288

Trading Information

Sinopharm Group Co. Ltd. Stock Price History

Beta (5Y Monthly) 0.819157
52-Week Change 40.58%
S&P500 52-Week Change 20.43%
52 Week High 3.25 EUR
52 Week Low 1.89 EUR
50-Day Moving Average 3.03 EUR
200-Day Moving Average 2.45 EUR

X2S.F Share Statistics

Avg. Volume (3 month) 2.72K EUR
Avg. Daily Volume (10-Days) 2.86K EUR
Shares Outstanding 1.34B
Float 183.2M
Short Ratio N/A
% Held by Insiders 0.012%
% Held by Institutions 53.28%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.82
Trailing Annual Dividend Yield 26.58%
5 Year Average Dividend Yield 345.00%
Payout Ratio 0.2728
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 1.55%
Operating Margin (ttm) 4.14%
Gross Margin 8.60%
EBITDA Margin 4.55%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 553.68B EUR
Revenue Per Share (ttm) 177.45 EUR
Quarterly Revenue Growth (yoy) -85.39%
Gross Profit (ttm) 47.43B EUR
EBITDA 25.21B EUR
Net Income Avi to Common (ttm) 8.64B EUR
Diluted EPS (ttm) 0.35
Quarterly Earnings Growth (yoy) -74.59%

Balance Sheet

Total Cash (mrq) 55.22B EUR
Total Cash Per Share (mrq) 129.59 EUR
Total Debt (mrq) 69.59B EUR
Total Debt/Equity (mrq) 63.22 EUR
Current Ratio (mrq) N/A
Book Value Per Share (mrq) 21.702

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Sinopharm Group Co. Ltd.

Country Germany
State N/A
City Shanghai
Address Sinopharm Group Building
ZIP 200023
Phone 86 21 2305 2666
Website https://www.sinopharmgroup.com.cn
Industry Medical Distribution
Sector(s) Healthcare
Full Time Employees 114766

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Q&A For Sinopharm Group Co. Ltd. Stock

What is a current X2S.F stock price?

Sinopharm Group Co. Ltd. X2S.F stock price today per share is 2.29 EUR.

How to purchase Sinopharm Group Co. Ltd. stock?

You can buy X2S.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Sinopharm Group Co. Ltd.?

The stock symbol or ticker of Sinopharm Group Co. Ltd. is X2S.F.

Which industry does the Sinopharm Group Co. Ltd. company belong to?

The Sinopharm Group Co. Ltd. industry is Medical Distribution.

How many shares does Sinopharm Group Co. Ltd. have in circulation?

The max supply of Sinopharm Group Co. Ltd. shares is 3.15B.

What is Sinopharm Group Co. Ltd. Price to Earnings Ratio (PE Ratio)?

Sinopharm Group Co. Ltd. PE Ratio is 6.19189170 now.

What was Sinopharm Group Co. Ltd. earnings per share over the trailing 12 months (TTM)?

Sinopharm Group Co. Ltd. EPS is 0.37 EUR over the trailing 12 months.

Which sector does the Sinopharm Group Co. Ltd. company belong to?

The Sinopharm Group Co. Ltd. sector is Healthcare.